ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank25
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-4.47
↑ 56% vs avg
Percentile
P25
Within normal range
Streak
3 yr
Consecutive declineContracting
Average
-10.15
Historical baseline
PeriodValueYoY Change
TTM-4.47-74.6%
2024-2.56-18.0%
2023-2.17-97.3%
2022-1.10+97.3%
2021-40.44-